ArticleCureus2022
Osteosarcoma of the Distal Femur Presenting as Giant Cell Tumor: A Case Report.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The most frequent benign bone tumor, known as a giant cell tumor (GCT), typically develops in the second and third decades of life. GCTs of the bone that have already been diagnosed and have already undergone treatment with denosumab therapy, curettage or excision, or radiotherapy frequently develop malignant transformation. A very uncommon occurrence involves a GCT of the bone that has always been malignant. Here, we describe the case of a 25-year-old man with a large cell tumor of the distal femur discovered after six months of symptom onset. The MRI suggested an aneurysmal bone cyst or subsequent modifications of an aneurysmal bone cyst in a GCT. A biopsy was performed, and the results pointed to a benign GCT of the bone. There were no pleomorphic or hyperchromatic lesions, unusual mitoses, or cellular atypia. The patient was treated with tumor removal and internal fixation using plate osteosynthesis two weeks later. The samples were sent for histopathology. The report was suggestive of osteogenic sarcoma or malignant transformation of the giant cell. This could happen due to the possibility of a biopsy sample being taken from an area not representative of the tumor site, which is not uncommon since the osteosarcoma also contains areas of conventional GCT. Thus, osteosarcoma usually mimics conventional GCT of the bone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.